04Mar
HHS Gives New Guidance on Drug Manufacturer Coupons and Out-of-Pocket Maximums
In April 2019, the Department of Health and Human Services (HHS) released guidance indicating that a health plan must include the value of financial assistance received from a drug manufacturer (often referred to as a “coupon” or “copay card”) when...
By:
Foley & Lardner LLP
Related
As part of a marathon finish to the 2019 legislative session, the New York State legislature recentl...
Read More >
California recently enacted AB 1554 which purportedly requires an employer to notify employees of an...
Read More >
On Jan. 28, 2020, the Federal Trade Commission announced revised thresholds for pre-merger filings u...
Read More >
One of the ongoing questions from members of Board of Directors is how to resolve the tension betwee...
Read More >
In New York, 2020 will be the last year employers who employ tipped employees in car washes, nail sa...
Read More >
M&A is nothing new to the cannabis sector. The industry has experienced substantial consolidation ac...
Read More >